Merck Q3 Earnings Preview: Analysts project ~50% EPS growth as Keytruda remains in focus

12 hours ago 1
Merck & Co. headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Merck (NYSE:MRK) is set to report its third-quarter earnings on Thursday, October 30, before the market opens.

Consensus estimates call for earnings per share of $2.35, up 49.7% year over year, and revenue of $16.98 billion, reflecting a 1.7% increase from the same period last

Quick Insights

    Recommended For You

    More Trending News

    Read Entire Article